GLP-1s are one of the most powerful tools in modern medicine offering benefits that may extend beyond weight loss to better metabolic health, cardiovascular function, and inflammation reduction
For example, a study published last year found that people with diabetes who used GLP-1 agonists had a significantly lower risk of 10 obesity related malignancies
We often recommend looking for a diverse multi-strain formula rather than a single-strain supplement
For a category fragmenting this fast, into this many specialized molecules, with this many distinct side-effect profiles and indication-by-indication tradeoffs, trial-and-error is going to look increasingly like flying blind
Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF
But it does not mean that they will be covered by any given plan